Core Viewpoint - Mitsui Chemicals has invested in the UK-based startup Hoxton Farms through its 321FORCE™ global innovation fund, focusing on cell-cultured fat production to create healthier and customizable food options [1][2]. Group 1: Company Overview - Hoxton Farms combines molecular biology, mathematical modeling, and machine learning to produce cell-cultured fat, branded as Hoxton Fat, which aims to lower production costs and risks [1]. - The company is collaborating with Sumitomo Corporation to promote Hoxton Fat in Japan and the Asia-Pacific market, integrating it into various food products [2]. Group 2: Market Context - The demand for meat in Asia is projected to increase by 78% by 2050, driven by rising incomes, urbanization, and population growth, leading to a significant rise in obesity and related healthcare costs [3]. - Over 40% of adults in the Asia-Pacific region are overweight or obese, with healthcare expenditures related to obesity accounting for 12% of total medical costs [3]. Group 3: Industry Trends - Precision fermentation technology is redefining the boundaries of functional foods, with a growing number of companies entering the field [5]. - Key future issues in the industry will include transitioning from technology development to large-scale commercialization and regulatory safety systems, while meeting consumer demands for health and sustainability [5].